'

CTRad Radiotherapy DDRi Combinations Workshop

'

This whole day meeting brought together just under 80 people: scientists from academia and industry, statisticians, clinicians, patient advocates and funding bodies with all their different experience and perspectives on the issues surrounding combining DDR inhibitors (DDRi) with radiotherapy.…

Read More

'

CM-Path consensus statement published in the BJC on the development and implementation of molecular diagnostic tests in the United Kingdom

'

Pathology has evolved from a purely morphological description of cellular alterations in disease to our current ability to interrogate tissues with multiple ‘omics’ technologies. By utilising these techniques and others, ‘molecular diagnostics’ acts as the cornerstone of precision/personalised medicine by attempting to match the underlying disease mechanisms to the most appropriate targeted therapy.…

Read More